Clinical trial
Development of an Atrial Fibrillation Prediction Model Using Polygenic Risk Score: A Prospective Cohort Study
NCT07641582 is registered in ClinicalTrials.gov with Seoul St. Mary's Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Development of an Atrial Fibrillation Prediction Model Using Polygenic Risk Score: A Prospective Cohort Study
- Lead sponsor
- Seoul St. Mary's Hospital
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- November 19, 2024
- Completion date
- June 30, 2027
- Enrollment
- 800 (estimated)
- Sites
- 5
Conditions
As the registry lists them; a condition with its own page is linked.
atrial fibrillation (af)